RU2015138708A3 - - Google Patents

Download PDF

Info

Publication number
RU2015138708A3
RU2015138708A3 RU2015138708A RU2015138708A RU2015138708A3 RU 2015138708 A3 RU2015138708 A3 RU 2015138708A3 RU 2015138708 A RU2015138708 A RU 2015138708A RU 2015138708 A RU2015138708 A RU 2015138708A RU 2015138708 A3 RU2015138708 A3 RU 2015138708A3
Authority
RU
Russia
Application number
RU2015138708A
Other languages
Russian (ru)
Other versions
RU2671400C2 (ru
RU2015138708A (ru
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/016071 external-priority patent/WO2014127025A1/en
Publication of RU2015138708A publication Critical patent/RU2015138708A/ru
Publication of RU2015138708A3 publication Critical patent/RU2015138708A3/ru
Application granted granted Critical
Publication of RU2671400C2 publication Critical patent/RU2671400C2/ru

Links

RU2015138708A 2013-02-13 2014-02-12 Фармацевтические композиции для лечения от helicobacter pylori RU2671400C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361764385P 2013-02-13 2013-02-13
US201361764401P 2013-02-13 2013-02-13
US61/764,401 2013-02-13
US61/764,385 2013-02-13
PCT/US2014/016071 WO2014127025A1 (en) 2013-02-13 2014-02-12 Pharmaceutical compositions for the treatment of helicobacter pylori

Publications (3)

Publication Number Publication Date
RU2015138708A RU2015138708A (ru) 2017-03-17
RU2015138708A3 true RU2015138708A3 (enExample) 2018-02-13
RU2671400C2 RU2671400C2 (ru) 2018-10-31

Family

ID=51297592

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015138708A RU2671400C2 (ru) 2013-02-13 2014-02-12 Фармацевтические композиции для лечения от helicobacter pylori

Country Status (26)

Country Link
US (8) US9050263B2 (enExample)
EP (1) EP2956149B1 (enExample)
JP (1) JP6494529B2 (enExample)
KR (1) KR102062357B1 (enExample)
CN (2) CN109893516A (enExample)
AU (1) AU2014216373B2 (enExample)
BR (1) BR112015019264B1 (enExample)
CA (1) CA2900763C (enExample)
CL (1) CL2015002253A1 (enExample)
CY (1) CY1122113T1 (enExample)
DK (1) DK2956149T3 (enExample)
ES (1) ES2744406T3 (enExample)
HK (1) HK1217645A1 (enExample)
HR (1) HRP20191559T1 (enExample)
HU (1) HUE052411T2 (enExample)
IL (1) IL240387B (enExample)
MX (1) MX368536B (enExample)
NZ (1) NZ711754A (enExample)
PH (1) PH12015501783B1 (enExample)
PL (1) PL2956149T3 (enExample)
PT (1) PT2956149T (enExample)
RU (1) RU2671400C2 (enExample)
SG (1) SG11201506318QA (enExample)
SI (1) SI2956149T1 (enExample)
UA (1) UA120249C2 (enExample)
WO (1) WO2014127025A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20191559T1 (hr) 2013-02-13 2019-11-29 Redhill Biopharma Ltd Farmaceutski pripravci za liječenje infekcije bakterijom helicobacter pylori
KR101884230B1 (ko) * 2016-02-29 2018-08-01 주식회사 유영제약 에소메프라졸을 포함하는 제제
JP2018149269A (ja) * 2017-01-18 2018-09-27 マッカイ メディカル ファンデーション ザ プレスビュテロス チャーチ イン タイワン マッカイ メモリアル ホスピタル 消化管感染症に対する管腔内治療システム
EP3551186A4 (en) * 2017-10-15 2020-08-19 The Center for Digestive Diseases COMPOSITIONS AND METHODS FOR THE TREATMENT, IMPROVEMENT AND PREVENTION OF H. PYLORI INFECTIONS
CN108497546B (zh) * 2018-03-22 2021-03-19 宝可科技(上海)有限公司 一种烟用添加剂及其制备方法和用途
CN110354125A (zh) * 2019-08-12 2019-10-22 珠海赛隆药业股份有限公司 一种治疗幽门螺杆菌感染的组合物及其制剂和用途
US11878011B2 (en) 2020-05-07 2024-01-23 Redhill Biopharma Ltd. Method for eradicating Helicobacter pylori infection in patients regardless of body mass index
WO2023204640A1 (ko) * 2022-04-22 2023-10-26 한국생명공학연구원 헬리코박터 파일로리에 의한 위 점막 손상 관련 질환의 예방 또는 치료용 약학적 조성물 및 헬리코박터 파일로리 감염의 예방 또는 치료용 유효성분의 스크리닝 플랫폼
CN116036123B (zh) * 2023-02-14 2026-03-27 山东齐都药业有限公司 用于治疗幽门螺旋杆菌感染的复方蒙脱石颗粒及其制备方法
CN117398360B (zh) * 2023-12-14 2024-03-15 山东齐都药业有限公司 治疗幽门螺杆菌的复方制剂胶囊及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980637A (en) * 1975-03-17 1976-09-14 Bristol-Myers Company Production of amoxicillin
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
WO1998022117A1 (en) 1996-11-22 1998-05-28 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
SE9700885D0 (sv) 1997-03-12 1997-03-12 Astra Ab New pharmaceutical formulation
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
AUPP325398A0 (en) * 1998-04-30 1998-05-21 Borody, Thomas J. Improved method for eradicating h. pylori
US5927500A (en) * 1998-06-09 1999-07-27 Milliken & Company Pharmaceutical containment package
JP2000128779A (ja) * 1998-10-20 2000-05-09 Mitsui Chemicals Inc 薬物放出制御型製剤
US20040213847A1 (en) * 2003-04-23 2004-10-28 Matharu Amol Singh Delayed release pharmaceutical compositions containing proton pump inhibitors
WO2005048979A2 (en) * 2003-10-06 2005-06-02 Torrent Pharmaceuticals Limited Pharmaceutical composition having casing with multiple micro tablets
US7981908B2 (en) * 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
FR2891459B1 (fr) 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
EP1803450A1 (en) * 2006-01-03 2007-07-04 Ferrer Internacional, S.A. Pharmaceutical compositions for the eradication of helicobacter pylori
JP5755878B2 (ja) * 2007-07-06 2015-07-29 ルパン リミテッドLupin Limited リファキシミンの薬剤組成物
JP5260905B2 (ja) 2007-07-12 2013-08-14 株式会社ジャパンディスプレイ 有機el表示装置
US8133739B2 (en) 2007-07-20 2012-03-13 Kowa Co., Ltd. Reagent for measurement of concentration of lead, and method for measurement of concentration of lead
MX2010001071A (es) * 2007-07-27 2010-03-09 Depomed Inc Formas de dosificacion retentivas gastricas pulsatiles.
CN101584681A (zh) * 2008-05-23 2009-11-25 黑龙江福和华星制药集团股份有限公司 一种用于治疗幽门螺旋杆菌感染的片剂胶囊
CN101607086B (zh) * 2009-07-21 2011-11-02 山西安特生物制药股份有限公司 一种复方铋剂组合物及其制备方法
CN102091084B (zh) * 2010-12-09 2012-05-09 王勇 一种复方胶囊及其制备方法
HRP20191559T1 (hr) * 2013-02-13 2019-11-29 Redhill Biopharma Ltd Farmaceutski pripravci za liječenje infekcije bakterijom helicobacter pylori

Similar Documents

Publication Publication Date Title
BR112021000792B8 (enExample)
AT524834A2 (enExample)
AT521543A3 (enExample)
AT524961A5 (enExample)
AT524266A2 (enExample)
BR102019026286B1 (pt) Método e aparelho para o avanço de produtos a serem moldados
BR102019025884B1 (pt) Sistema de segurança aprimorado para máquinas de operação de autopropulsão
BR102019023514B1 (pt) Método para determinar a massa de ar preso em cada cilindro de um motor a combustão interna
BR112020016338B1 (pt) Dispositivo para tratamento de tecido corporal
BR112021001374B1 (pt) Composição farmacêutica para o tratamento da hipertensão e seu uso
BR112021001128B1 (pt) Composição de cimento para impressão 3d, método de impressão 3d, kit para a preparação de uma composição de cimento para impressão 3d e método de impressão 3d implementando o kit
BR112021000922B1 (pt) Tela de filtro, e, método para purificar água de alimentação
BR112020026077B1 (pt) Recipiente com estrutura encaixável
BR112020026721B1 (pt) Aparelho de moldagem para modar uma folha de um material contendo alcaloides
BR102019012845B1 (pt) Montagens de guia de entrada de piso de compartimento de carga retráteis para carregamentos paletizados em aeronaves de carga e aeronave e carga
BR112020023832B1 (pt) Amostra de calibração de sistemas de análise multiespectral e método para calibração de sistemas de análise multiespectral
BR112020024987B1 (pt) Método, montagem e sistema para prover uma estrutura de base, método industrial, e, braço mecânico
BR112020023823B1 (pt) Distribuidor
BR112020022482B1 (pt) Composição, anticorpo anti-cd24, anticorpo biespecífico e receptor de antígeno quimérico
BR112020022658B1 (pt) Método para estimar um nível de pressão sonora, sistema de fone de ouvido, fone de ouvido e uso do fone de ouvido
BR112020022516B1 (pt) Processo para degomagem enzimática de óleo
BR112020021042B1 (pt) Compostos de carboxamidas bicíclicas, composição farmacêutica e uso das mesmas
BR112020020812B1 (pt) Composições de tratamento de superfícies duras, seu uso, método para proporcionar ação antimicrobiana residual e substrato relacionado
BR102019000241B1 (pt) Veículo modular, configurável, sobre plataforma de chassis comum, e métodos e sistemas associados
BR102018073077B1 (pt) Processo de extração de gelatina de resíduos de couro curtido ao cromo wet blue